Organigram Announces $50 Million Bought Deal For Incremental 40,000 kg/year Expansion

Organigram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) announces that it has entered into a letter of engagement with Eight Capital under which Eight Capital has agreed to purchase, together with a syndicate of Underwriters 14,285,715 units of the Company on a "bought deal" basis pursuant to the filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $3.50 for gross proceeds of $50,000,003..

Canopy Growth Adds Manitoba-Based Licensed Producer Delta 9 to the CraftGrow Family

Canopy Growth Corporation (TSX: WEED) enters into a distribution agreement with Winnipeg-based Delta 9 Cannabis Inc. (TSXV: NINE). Delta 9 will offer their well-established cannabis products through Canopy Growth's curated CraftGrow line via Tweed Main Street's online store, alongside other high-quality cannabis varieties grown by a diverse set of producers.

ABcann to Raise $30 Million through Convertible Debentures

ABcann Global Corporation (TSXV:ABCN) announces that it has entered into a binding interim agreement with respect to a proposed private placement of convertible senior unsecured debentures in the aggregate principal amount of $30,000,000.

Aurora's BC Northern Lights and Namaste Technologies Sign Supply Agreement

Aurora Cannabis Inc. (TSX: ACB) (OTCQX: ACBFF) and Namaste Technologies Inc.(CSE: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) announce that Aurora's wholly owned subsidiary BC Northern Lights ("BCNL") and Namaste Technologies have signed a Hardware Supply Agreement whereby Namaste will be the first third-party distributor to sell BCNL's premium home cultivation systems and accessories through its online technology platform.

Canopy Rivers Corporation to Support Micro Growers

Canopy Growth Corporation (TSX: WEED) is pleased to announce that its affiliate Canopy Rivers Corporation ("Canopy Rivers") is making a special allocation of capital towards investing in and supporting micro growers and processors, as proposed under the Government of Canada's consultation paper on the new cannabis regulatory framework


These 5 Biotechs including InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) have a combined market cap of over $4 Billion. What should investors know about future growth for these companies?